Literature DB >> 27657853

Notes from the Field: Furanyl-Fentanyl Overdose Events Caused by Smoking Contaminated Crack Cocaine - British Columbia, Canada, July 15-18, 2016.

Salman A Klar, Elizabeth Brodkin, Erin Gibson, Shovita Padhi, Christine Predy, Corey Green, Victoria Lee.   

Abstract

On July 15 2016, Surrey Memorial Hospital's emergency department notified the medical health officer on call of a sharp increase in opioid overdose events in Surrey, Fraser Health Authority, in British Columbia, Canada. During July 15-18, the number of persons with suspected opioid overdose evaluated in Surrey Memorial Hospital's emergency department increased approximately 170%, from an average of four suspected cases per day during the period January-June 2016 to 43 (nearly 11 per day) during the 4-day period (Figure). Most patients (22 [51%]) became unconscious after smoking what they believed to be crack cocaine. The majority of overdose events occurred within a small geographic area in Surrey that has a high population of homeless persons and persons who use illicit drugs, including opioids and crack cocaine. Most cases occurred in males (36 cases [84%]); the average age of the patients was 42 years (range = 18-63 years). Forty (93%) patients were brought to the emergency department by ambulance. A total of 37 (86%) patients received injectable naloxone before arriving in the emergency department, including 12 who received it only from community members, 16 who received it only from paramedics, five who received it from both community members and paramedics, one who received it from the fire department and paramedics, and one who received it from the fire department, community, and paramedics; for two patients, the source of naloxone was not known. Reports from first responders, the community, and emergency department staff members indicated that patients required high doses of injectable naloxone, in some cases up to 3.0 mg (usual dose = 0.4 mg). Thirty-five (81%) patients were treated and discharged within a few hours, two patients left without being seen by a health care provider, and six patients were admitted to the hospital; among these, three were transferred to the intensive care unit, one of whom died.

Entities:  

Year:  2016        PMID: 27657853     DOI: 10.15585/mmwr.mm6537a6

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  31 in total

Review 1.  Naloxone dosage for opioid reversal: current evidence and clinical implications.

Authors:  Rachael Rzasa Lynn; J L Galinkin
Journal:  Ther Adv Drug Saf       Date:  2017-12-13

2.  Canadian trends in opioid-related mortality and disability from opioid use disorder from 1990 to 2014 through the lens of the Global Burden of Disease Study.

Authors:  Heather M Orpana; Justin J Lang; Maulik Baxi; Jessica Halverson; Nicole Kozloff; Leah Cahill; Samiah Alam; Scott Patten; Howard Morrison
Journal:  Health Promot Chronic Dis Prev Can       Date:  2018-06       Impact factor: 3.240

3.  Overdose Research: 15 Years Later.

Authors:  Phillip O Coffin; Josiah D Rich
Journal:  J Urban Health       Date:  2019-02       Impact factor: 3.671

4.  Temporal changes in non-fatal opioid overdose patterns among people who use drugs in a Canadian setting.

Authors:  Christopher Fairgrieve; Ekaterina Nosova; M-J Milloy; Nadia Fairbairn; Kora DeBeck; Keith Ahamad; Evan Wood; Thomas Kerr; Kanna Hayashi
Journal:  Subst Abus       Date:  2020-04-29       Impact factor: 3.716

5.  Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: A cross-sectional urine toxicology screening study.

Authors:  Kanna Hayashi; M-J Milloy; Mark Lysyshyn; Kora DeBeck; Ekaterina Nosova; Evan Wood; Thomas Kerr
Journal:  Drug Alcohol Depend       Date:  2017-12-06       Impact factor: 4.492

6.  Elevated prevalence of self-reported unintentional exposure to fentanyl among women who use drugs in a Canadian setting: A cross-sectional analysis.

Authors:  Sanjana Mitra; Jade Boyd; Evan Wood; Cameron Grant; M-J Milloy; Kora DeBeck; Thomas Kerr; Kanna Hayashi
Journal:  Int J Drug Policy       Date:  2020-07-20

7.  Safety of a Modified Community Trailer to Manage Patients with Presumed Fentanyl Overdose.

Authors:  Frank X Scheuermeyer; Eric Grafstein; Jane Buxton; Keith Ahamad; Mark Lysyshyn; Stan DeVlaming; Gerrit Prinsloo; Christopher Van Veen; Andrew Kestler; Reka Gustafson
Journal:  J Urban Health       Date:  2019-02       Impact factor: 3.671

8.  Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic.

Authors:  Nadia Fairbairn; Phillip O Coffin; Alexander Y Walley
Journal:  Int J Drug Policy       Date:  2017-07-04

9.  The emergence of innovative cannabis distribution projects in the downtown eastside of Vancouver, Canada.

Authors:  Jenna Valleriani; Rebecca Haines-Saah; Rielle Capler; Ricky Bluthenthal; M Eugenia Socias; M J Milloy; Thomas Kerr; Ryan McNeil
Journal:  Int J Drug Policy       Date:  2020-04-11

10.  Fentanyl and heroin contained in seized illicit drugs and overdose-related deaths in British Columbia, Canada: An observational analysis.

Authors:  Nicholas Baldwin; Roger Gray; Anirudh Goel; Evan Wood; Jane A Buxton; Launette Marie Rieb
Journal:  Drug Alcohol Depend       Date:  2018-02-20       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.